Ambit Health Ventures
Venture capitalBoston · Seed–Series B · 3 people tracked
Investment thesis
Ambit Health Ventures invests in early-stage digital health companies solving for patients, physicians, and payors. The firm prioritizes innovations in digital diagnostics, digital therapeutics, and tech-enabled services where commercialization is imminent and founders have a clear competitive advantage. The firm leverages clinical expertise, operational experience scaling healthcare ventures, and deep understanding of the healthcare ecosystem to support portfolio company growth.
Source: firm website, verified Aug 5, 2026.
Team · 3 people
from the firm's website & public directories
What they invest in
from 13 of 14 portfolio companiesMedical Devices ×10Biotech ×7Digital Health ×7AI & Machine Learning ×6Healthtech ×6FemTech ×2Hardware ×1
HQs:United States×8
Investments · 14 tracked
founders shown can be your intro pathBy year:2024 · 22023 · 32022 · 12021 · 12011 · 18 dated
Encapsulate builds automated tumor-on-a-chip systems that test microtumors derived from patient biopsies against treatment regimens to predict how individual cancer patients will respond, delivering personalized insights in under seven days.
BiotechHealthtechMedical Devices
Armin Rad(Co-founder & CEO)inLeila Daneshmandi(Co-founder & COO)inArmin Rad, Ph.D.(Founder)inBret Schipper(CMO)inJohn Strahley(CFO)in
Co-investorsConnecticut Innovations
Osteoboost is an FDA-cleared, drug-free prescription device that uses precision vibration therapy to slow bone density and strength loss in postmenopausal women with osteopenia.
Digital HealthFemTechMedical Devices
Dan Burnett(Co-Founder)Michael Jaasma(Chief Scientific Officer and Co-Founder)Shane Mangrum(Co-Founder)Laura Yecies(Chief Executive Officer & President)inPamela M. Peeke(Chief Medical Officer)
Co-investorsEsplanade VenturesBand of AngelsGolden SeedsGood Growth CapitalHealthtech CapitalNew York Angels+2 more
Osteoboost is an FDA-cleared, drug-free prescription device that delivers precision vibration therapy to slow bone loss in postmenopausal women with osteopenia.
BiotechFemTechHealthtechMedical DevicesRedwood City, US
Daniel Burnett(Executive Officer, Director)Michael Jaasma(Director)John Osborne(Director)
Board seatSam Goldberger· per SEC Form D
Co-investorsBand of AngelsHouston Angel NetworkIT-Farm CorporationPortfoliaReno Seed FundGolden Seeds
BiotechHanover, US
Jeff Sabados(Executive Officer, Director)
BoardGreg Keenan(Director)
Board seatSam Goldberger· per SEC Form D · $11.1M raise · filed Oct 2024
SurgiBox develops surgical technology co-developed with users to enable safe surgery for patients and healthcare providers, focused on delivering safe surgical care regardless of location.
BiotechHardwareHealthtechMedical DevicesCambridge, US
Debbie Teodorescu(Founder & Board Member)inKelly Laurel(CEO)inAtif Rakin(CTO)inKaren Pinto(VP)inMike Teodorescu(Co-Founder & Board Member)inJulian Greene(Executive Officer)
Board seatSam Goldberger· per SEC Form D
AEYE Health makes AEYE-DS, an FDA-cleared autonomous AI system that screens for diabetic retinopathy using portable and tabletop retinal cameras, producing a diagnostic report in about a minute without physician interpretation.
AI & Machine LearningDigital HealthMedical Devices
Zack Dvey-Aharon(Founder)
BRAINBox Solutions develops a multi-modality diagnostic approach for mild traumatic brain injury (mTBI), combining blood biomarker panels with tablet-based neurocognitive testing to produce an objective injury score and a prognosis of post-injury symptoms.
AI & Machine LearningBiotechDigital HealthMedical DevicesHouston, US
Steve Wallace(Chief Operating Officer, Global Supply Chain Management)Donna J. Edmonds(CEO)inJames V. Snider(Chief Technology Officer / Advisor)Tim Van Meter(Chief Scientific Officer)Richard Noel(Chief Product and Commercial Officer)Robert Sledd(Director)
Co-investorsBioventures InvestorsGenoa VenturesVTC VenturesGENERAL INCEPTION
Head Diagnostics develops AI-driven digital tools for neurological assessment, including HDx Cognition, a cloud-based cognitive assessment platform (formerly Philips IntelliSpace Cognition), and the iTremor handheld device that measures ocular microtremor.
AI & Machine LearningDigital HealthMedical Devices
BiotechDanbury, US
Solomon S. Steiner(Executive Officer, Director)Edith Mathiowitz(Executive Officer, Director)Erik Steiner(Executive Officer)Peter van Straelen(Executive Officer)James C. Costin(Executive Officer)Philip N. Sussman(Executive Officer)
Perosphere is a medical technology company developing point-of-care coagulation diagnostics, including a pharmacodynamic test that provides a global view of a patient's coagulation status.
BiotechHealthtechMedical DevicesDanbury, US
Sasha H. Bakhru(Founder, President & CEO)Sasha Bakhru(Founder)inSolomon Steiner(Director)Michelle Brennan(Director)Daryl Mootoo(Executive Officer)Bakhru Sasha(Executive Officer, Director)
Co-investorsConnecticut Innovations
Smartlens develops ophthalmic technologies for anterior segment disease management, including miLens, a non-invasive wearable microfluidic contact lens for remote intraocular pressure monitoring, an AI-powered remote examination platform for anterior segment conditions, and an automated micro-dose medication delivery device.
AI & Machine LearningDigital HealthMedical Devices
Co-investors3E Bioventures Capital
SOAP Health builds an EHR-integrated, voice-based conversational AI assistant that uses an animated digital human to conduct patient interviews, collect medical histories, assess risk, and generate pre-completed SOAP notes.
AI & Machine LearningDigital HealthHealthtechBoca Raton, US
Steven Charlap(Executive Officer, Director, Promoter)Steve Charlap(MD)
Rapid home diagnostic for ear infections using mobile phone-based acoustic reflectometry.
WavelyDx offers an FDA-listed acoustic scanning device and companion smartphone app that lets parents check their child's ears at home for signs of an ear infection.
AI & Machine LearningDigital HealthHealthtechMedical DevicesSeattle, US
Shyamnath Gollakota(Director, Promoter)Randall Bly(Director, Promoter)inArna Ionescu Stoll(Chief Executive Officer)inJacob Reider(Chief Health, Privacy, & Security Officer)inJoe Cotellese(VP of Technology)inJud Heugel(Executive Officer)
Co-investorsHealthtech CapitalLong Way VenturesRobin Hood VenturesSymphonic CapitalWealthing VC ClubWXR Fund+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Portfolio news
latest coverage across their companiesEncapsulate · today.uconn.edu · Oct 13, 2025
Frequently asked questions
- How many investments has Ambit Health Ventures made?
- Ambit Health Ventures has 12 tracked investments.
- What stage does Ambit Health Ventures invest at?
- Ambit Health Ventures invests at the Seed, Series A, Series B stages.
- What sectors does Ambit Health Ventures focus on?
- Ambit Health Ventures focuses on Digital Health, Healthtech, Medical Devices.
- Where is Ambit Health Ventures located?
- Ambit Health Ventures is headquartered in Boston, US.
- Does Ambit Health Ventures lead rounds?
- Yes, Ambit Health Ventures leads investment rounds.
- Who does Ambit Health Ventures co-invest with?
- Ambit Health Ventures most often shares deals with Connecticut Innovations, Genoa Ventures, Long Way Ventures, among 15 tracked co-investors.
Co-investors · 5
Connecticut Innovations is the state of Connecticut's investment arm, providing capital and strategic support to early stage and growth companies across multiple funds.
Good Growth Capital is a venture firm that invests exclusively in impact sectors aligned with the UN Sustainable Development Goals, pursuing strong financial returns while meeting diversity and UNDP impact metrics across its portfolio.
Emmeline Ventures is an investment firm backing female founders building businesses that help women manage their health, build wealth, and live in a cleaner, safer world. It also provides portfolio support including capital-raising help, pitch deck reviews, and strategic and operational consulting.
WRF Capital invests in venture-backed companies and operates as the investment arm of the Washington Research Foundation, established in 1981. The firm focuses on commercializing technology emerging from Washington state research institutions and universities.
Firms observed investing alongside Ambit Health Ventures, from public investor directories. Shared companies are the overlap with Ambit Health Ventures's recorded portfolio.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.